Disclaimer
We’re actively expanding Guideline Genius to cover the full UKMLA content map. You may notice some conditions not uploaded yet, or articles that only include diagnosis and management for now. For updates, follow us on Instagram @guidelinegenius.
We openly welcome any feedback or suggestions through the anonymous feedback box at the bottom of every article and we’ll do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 326

Candidiasis (Vulvovaginal)

NICE CKS Candida – female genital. Last revised: Oct 2023.
BASHH Vulvovaginal Candidiasis 2019. Last updated: Jan 2021.

13/02/26: Partner management added under acute infection section

 

Background Information

Definitions

Vulvovaginal candidiasis (genital thrush): symptomatic inflammation of the vagina and/or vulva secondary to fungal infection.

Recurrent infection: ≥4 symptomatic episodes in 1 year, at least 2 confirmed by microscopy / culture (at least one by culture)

Causative Agent

Most common genus: Candida yeasts

  • Most common species: Candida albicans (80-89% cases)
  • Candida glabrata (5%)

Risk Factors

  • Local irritants – douching, soaps, shampoos, shower gels
  • Recent antibiotic use (within 3 months)
  • Immunosuppression
    • Poorly controlled diabetes mellitus
    • HIV infection
    • Long-term corticosteroid use
  • Oestrogen exposure
    • Pregnancy
    • COCP
    • HRT

Clinical Features

Possible symptoms:

  • Vulval / vaginal itching (most common), soreness and irritation
  • Superficial dyspareunia and dysuria

On examination:

  • White ‘cheese-like’ discharge (non-malodorous)
  • Erythema
  • Vaginal fissuring and/or oedema
  • Excoriations
  • Satellite lesions (often associated with more severe/extensive disease)

Guidelines

Investigation and Diagnosis

Clinical diagnosis is usually sufficient in the presence of typical signs and symptoms

Consider the following for recurrent infection / diagnostic uncertainty:

High vaginal swab for microscopy
  • Self-collected low vulvovaginal swab is also appropriate (if examination of external genitalia not possible or not needed)
  • Culture might be needed for recurrent infection
Vaginal pH testing of secretions
  • Normal pH (<4.5) supports candidiasis
  • Not needed for diagnosis, but helpful to exclude bacterial vaginosis and trichomoniasis
Midstream sample of urine 
  • If UTI is suspected
HbA1c
  • To exclude diabetes mellitus (esp. if recurrent infections)

Management

Acute Infection

Choice of anti-fungal (both oral and topical treatment gives similar cure rates):

  • 1st line: oral fluconazole (single dose)
  • 2nd line: topical therapies 
    • Preferred: intravaginal clotrimazole pessary (single dose)
    • Alternative: intravaginal antifungal creams (i.e, clotrimazole or miconazole)

Treatment Failure

Definition: if no response to initial treatment within 7-14 days

  • Perform a high vaginal swab 
  • Treat according to high vaginal swab results

Partner Management

Asymptomatic 

  • Contact tracing / treatment is NOT indicated

 

Symptomatic Male Partner

  • Suspected/confirmed candidal balanitis [Ref]
    • Imidazole cream untill symptoms settle OR for up to 14 days
    • Severe infection: oral fluconazole single dose

Recurrent Infection

Offer an induction-maintenance regimen:

  • Induction: 3 doses of oral fluconazole – to be taken every 72 hours
  • Maintenance: oral fluconazole once a week for 6 months

2nd line induction-maintenance regimen:

  • Induction: topical clotrimazole intravaginal pessary up to 7-14 days
  • Maintenance: topical clotrimazole intravaginal pessary once a week for 6 months OR oral itraconazole daily for 6 months

Infection During Pregnancy

Duration of treatment is 7 days (applied at night):

  • 1st line: topical clotrimazole intravaginal pessary
  • 2nd line: intravaginal anti-fungal creams (i.e, clotrimazole or miconazole)

Pregnant women generally need a longer duration of treatment (for 7 days) to clear the infection, as opposed to the single-dose treatment preferred in non-pregnant women.

Oral antifungals (including fluconazole) are generally contraindicated in pregnancy.

Topical antifungals ​​​​​​are safe alternatives in pregnancy, as there is limited systemic absorption from the vagina.

References


Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD